Richard Sutherland
Primary Care · Martinsburg, WVNPI 1588267488
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,324 of the $3,798 with a category attached, or 87.5%. It is spread thinly across 21 manufacturers, the largest accounting for just 16.7% — the pattern of someone who eats at a lot of different presentations. Among primary care clinicians in WV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 152 payments — averaging $24.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$635
- Regeneron Healthcare Solutions, Inc.$571
- AbbVie$416
- Novartis$384
- Organogenesis Inc.$356
- Incyte Corporation$183
- plus $1K from 15 others
What the payments were for
- Food & beverage$3,32488%
- Education$47412%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 22 | $635 |
| Regeneron Healthcare Solutions, Inc. | 19 | $571 |
| AbbVie | 20 | $416 |
| Novartis | 17 | $384 |
| Organogenesis Inc. | 15 | $356 |
| Incyte Corporation | 8 | $183 |
| Amgen | 4 | $181 |
| Lilly USA, LLC | 9 | $160 |
| E.r. Squibb & Sons, L.L.C. | 6 | $124 |
| Arcutis Biotherapeutics, Inc. | 5 | $110 |
| UCB, Inc. | 3 | $108 |
| Boehringer Ingelheim | 4 | $104 |
| Sun Pharmaceutical Industries Inc. | 4 | $101 |
| Convatec Inc. | 3 | $73 |
| Galderma Laboratories, L.p. | 3 | $65 |
| Pfizer | 3 | $58 |
| Strata Skin Sciences, Inc. | 1 | $47 |
| LEO Pharma Inc. | 2 | $46 |
| Dermavant Sciences, Inc. | 2 | $36 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $21 |
| Biofrontera Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Otezla$125
- CYGNUS DUAL$116
How this compares
$3,798 in reported general payments places this provider in the 90th percentile of 43 primary care providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 18 | $158,266 |
| Dupixent PenDupilumab | 42 | $154,173 |
| VtamaTapinarof | 11 | $15,045 |
| Tacrolimus | 50 | $12,271 |
| Clobetasol Propionate | 175 | $9,079 |
| Ketoconazole | 307 | $6,189 |
| Triamcinolone Acetonide | 354 | $4,535 |
| Fluorouracil | 44 | $2,634 |
| Doxycycline Hyclate | 67 | $1,813 |
| Hydrocortisone | 256 | $1,301 |
| Metronidazole | 33 | $1,225 |
| CiclopiroxCiclopirox Olamine | 48 | $1,203 |
| Clindamycin Phosphate | 31 | $1,114 |
| MethotrexateMethotrexate Sodium | 54 | $424 |
| Mupirocin | 53 | $396 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Dermavant Sciences, Inc.Vtama | $36 | $15,04511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 43 primary care providers in West Virginia.
Other primary care in Martinsburg
- Sharon RiceMartinsburg$165
- Misty KlineMartinsburg$23
- Amanda WakimWheeling$169K
- Brenda HashemBerkeley Springs$8K
- Brenda DennisGlen Dale$6K
- Molly WhiteCharleston$5K
- Kayla MeadeHuntington$3K
- Crystal Clark-CrookshanksSummersville$3K
- Jessica FrankeGlen Dale$2K
- Jerica BoboRomney$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.